[Editors' note: Follow progress with legislation impacting the device and diagnostics industry with Medtech Insight's US Congress Tracker.]
The House unanimously passed H.R. 2430, the FDA Reauthorization Act of 2017, which would reauthorize the MDUFA IV user-fee agreement for the next five years, including about $1bn in device...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?